Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with APLM: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
APLM
Apollomics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
APLM
Apollomics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
APLM: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
APLM, dashed
LLY
ELI Lilly & Co
Change
1,407.25
· pre 1,447.69
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
APLM
Apollomics Inc.
Change
21.21
· pre 20.56
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$45.8M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 4 '26
delayed
LLY
ELI Lilly & Co
vs
APLM
Apollomics Inc.
1,407.25
pre 1,447.69
delayed
Price
21.21
pre 20.56
delayed
$1.3T
Mkt cap
$45.8M
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,407.25
vs
APLM
21.21
Pre-market
Nov 4 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only APLM
3
—
Crown Bioscience (Taicang)
unlisted
supplier
—
GlycoMimetics
unlisted
supplier
—
Cttq
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR